TWO NEW DNA BASED TESTS AVAILABLE FOR THE NSDTR



Similar documents
VIP RECOMMENDED GENETIC AND HEALTH TESTS

Screening for Progressive Retinal Atrophy in Tibetan Terriers

Information Guide. Breeding for Health.

Published on: 07/04/2015 Page 1 of 5

Health screening and the Kennel Club

INTRODUCTION Thrombophilia deep vein thrombosis DVT pulmonary embolism PE inherited thrombophilia

INTRODUCTION Thrombophilia deep vein thrombosis DVT pulmonary embolism PE inherited thrombophilia

determined if they were worthy of continuing in future generations.

Summary of the risk management plan (RMP) for Orkambi (lumacaftor and ivacaftor)

UNIT 13 (OPTION) Genetic Abnormalities

Genetic Mutations. Indicator 4.8: Compare the consequences of mutations in body cells with those in gametes.

Cystic Fibrosis Webquest Sarah Follenweider, The English High School 2009 Summer Research Internship Program

Gene Therapy and Genetic Counseling. Chapter 20

With Dr. Julia A. Bates, DVM, DACVIM

Preimplantation Genetic Diagnosis. Evaluation for single gene disorders

Usher Syndrome Genetics

Worksheet - COMPARATIVE MAPPING 1

PRACTICE PROBLEMS - PEDIGREES AND PROBABILITIES

About The Causes of Hearing Loss

NORD Guides for Physicians #1. Physician s Guide to. Tyrosinemia. Type 1

Spinal Cord Diseases in Bernese Mountain Dogs

Less stress for you and your pet

What Is Genetic Counseling? Helping individuals and families understand how genetics affects their health and lives

Understanding Your Risk of Ovarian Cancer

Cystic Fibrosis. Cystic fibrosis affects various systems in children and young adults, including the following:

LEUKODYSTROPHY GENETICS AND REPRODUCTIVE OPTIONS FOR AFFECTED FAMILIES. Leila Jamal, ScM Kennedy Krieger Institute, Baltimore MD

Introductory genetics for veterinary students

REQUEST FOR IMAGe SYNDROME TESTING

1333 Plaza Blvd, Suite E, Central Point, OR *

1 ALPHA-1. The Liver and Alpha-1 Antitrypsin Deficiency (Alpha-1) FOUNDATION FOUNDATION. A patient s guide to Alpha-1 liver disease

Genetic Counseling: A Profession in the Making. Jessica Hooks, MS Genetic Counselor University of South Carolina

Lecture 6: Single nucleotide polymorphisms (SNPs) and Restriction Fragment Length Polymorphisms (RFLPs)

patient education Fact Sheet PFS007: BRCA1 and BRCA2 Mutations MARCH 2015

Preimplantation Genetic Diagnosis (PGD) for Fanconi Anemia and HLA matching

Genetics Test Biology I

CHROMOSOMES AND INHERITANCE

Birth defects. Report by the Secretariat

A trait is a variation of a particular character (e.g. color, height). Traits are passed from parents to offspring through genes.

Patient Information. for Childhood

Heredity. Sarah crosses a homozygous white flower and a homozygous purple flower. The cross results in all purple flowers.

Bio EOC Topics for Cell Reproduction: Bio EOC Questions for Cell Reproduction:

How does genetic testing work?

1 Mutation and Genetic Change

Diagnostic Scoring System for LQTS

Canine Hypoadrenocorticism. Diagnosis and Treatment

Study Partner/Essential Study Partner (ESP):

patient guide BRCA1 and BRCA2 Genetic Testing for Hereditary Breast and Ovarian Cancer

NIH Clinical Center Patient Education Materials Managing adrenal insufficiency

Congenital Anomalies In Diamond Blackfan Anemia (DBA)

Genetic testing. The difference diagnostics can make. The British In Vitro Diagnostics Association

a guide to understanding pierre robin sequence

STATE UNIVERSITY OF NEW YORK COLLEGE OF TECHNOLOGY CANTON, NEW YORK COURSE OUTLINE. BIOL 101 Introduction to Biology

Activity 7.21 Transcription factors

Genetic diagnostics the gateway to personalized medicine

Dogs and More Dogs. NOVA presents the story of dogs and how they evolved into the most diverse mammals on the planet.

Saving healthcare costs by implementing new genetic risk tests for early detection of cancer and prevention of cardiovascular diseases

BRCA Genes and Inherited Breast and Ovarian Cancer. Patient information leaflet

What s In Your Genes: How changes in the BRCA1/BRCA2 genes

The Case of Baby Joe by Kristen L.W. Walton Page 1

Report from the Kennel Club/ British Small Animal Veterinary Association Scientific Committee

Guidance For Research Involving Human Embryonic Stem Cells, Germ Cells, And Cells Obtained From Cord Blood

The Genetics of Early- Onset Breast Cancer. Cecelia Bellcross, Ph.D., M.S.,C.G.C. Department of Human Genetics Emory University School of Medicine

BRCA1 & BRCA2: Genetic testing for hereditary breast and ovarian cancer patient guide

Respiration occurs in the mitochondria in cells.

The impact of genomic selection on North American dairy cattle breeding organizations

Genetic Technology. Name: Class: Date: Multiple Choice Identify the choice that best completes the statement or answers the question.

The Developing Person Through the Life Span 8e by Kathleen Stassen Berger

Goiter. This reference summary explains goiters. It covers symptoms and causes of the condition, as well as treatment options.

This fact sheet describes how genes affect our health when they follow a well understood pattern of genetic inheritance known as autosomal recessive.

Ovarian Cancer Genetic Testing: Why, When, How?

Genetic Testing in Research & Healthcare

Mendelian and Non-Mendelian Heredity Grade Ten

FAQs: Gene drives - - What is a gene drive?

Organic Acid Disorders

MCB41: Second Midterm Spring 2009

Biotechnical Engineering (BE) Course Description

Reproductive System & Development: Practice Questions #1

Fact Sheet 14 EPIGENETICS

Optional Tests Offered Before and During Pregnancy

Information leaflet. Centrum voor Medische Genetica. Version 1/ Design by Ben Caljon, UZ Brussel. Universitair Ziekenhuis Brussel

GENETIC TESTING FOR INHERITED MUTATIONS OR SUSCEPTIBILITY TO CANCER OR OTHER CONDITIONS MED

Mendelian inheritance and the

DURATION OF HEARING LOSS

Gene mutation and molecular medicine Chapter 15

Understanding Hereditary Breast and Ovarian Cancer. Maritime Hereditary Cancer Service

Muscular Dystrophy. By. Tina Strauss

Polycystic Ovary Syndrome

Report from the Kennel Club/ British Small Animal Veterinary Association Scientific Committee

Lecture 3: Mutations

CORE MEDICAL TERMINOLOGY Course Syllabus

Regulations for Record Keeping and Identification of Dogs

SICKLE CELL ANEMIA & THE HEMOGLOBIN GENE TEACHER S GUIDE

The Liver and Alpha-1. Antitrypsin Deficiency (Alpha-1) 1 ALPHA-1 FOUNDATION

Year 10: The transmission of heritable characteristics from one generation to the next involves DNA

Transcription:

TWO NEW DNA BASED TESTS AVAILABLE FOR THE NSDTR Written by Danika Bannasch DVM PhD; Professor Department of Population Health and Reproduction, School of Veterinary Medicine, University of California-Davis Published Spring 2012 Issue-Quackers We are very excited to report two new DNA based tests available for the NSDTR, one for juvenile onset Addison s disease (JADD) and one for one form of cleft palate (CP1). The tests are available though the Orthopedic Foundation for Animals. Test kits (swab-based) will be ordered through OFA and the test results will be automatically included in the OFA database. Both of these tests are being offered to breeders prior to peer reviewed scientific publication in order to allow their immediate use in breeding programs. In both cases additional research is being conducted and when it is completed the information about the specific genes involved will be made available. We are also continuing to work on both Addison s disease and cleft palate in the NSDTR and want to strongly encourage breeders to continue sending samples. This will enable the identification of the additional cleft palate genes as well as help us clarify the nature of the JADD mutation. Email contact information for cleft palate is ztwolf@ucdavis.edu and for Addison s disease it is dlbannasch@ucdavis.edu The research on Addison s disease was funded by the Center for Companion Animal Health, University of California- Davis and the AKC Canine Health Foundation Acorn grant. The research on cleft palate was funded by the Center for Companion Animal Health, University of California-Davis, AKC Canine Health Foundation Oak grant, and the Lady Grey Foundation. We would like to thank the Tollers owners and breeders world-wide for submitting samples and veterinary information about their dogs. Without their contributions these tests would not have been possible. Juvenile Addison s disease (JADD) in the Nova Scotia Duck Tolling Retriever (NSDTR) Addison s disease (hypoadrenocorticism) occurs when the adrenal glands stop secreting the natural steroid hormones (glucocorticoid) and hormones (mineralicorticoids) necessary for the regulation of sodium and potassium levels in the blood. Addison s disease can occur in any breed of dog and it has an average age of onset of 4 years. Addison s disease is diagnosed by a veterinarian using a blood test called an ACTH stimulation test. The clinical signs of Addison s disease can include lethargy, inappetance, vomiting and diarrhea. In the NSDTR, a genetic form of this disease, called JADD, occurs in much younger animals. The average age of puppies affected with JADD is 5 months; however, puppies as young as 8 weeks and as old as 12 months of age have been identified. Treatment of puppies affected with JADD requires both mineralicorticoid and glucocorticoid replacement therapy. Puppies can have other concurrent diseases including eye problems (corneal edema, conjunctivitis or uveitis) that may require specialized treatment. Page 1 of 5

Discovery: Scientists from the Bannasch Laboratory at the University of California, Davis have developed a DNA test to identify carriers of JADD in the Nova Scotia Duck Tolling Retriever. The juvenile form of Addison s disease is genetically distinguishable from the adult onset form in that all dogs developing the juvenile form have two identical copies of a specific region within their genome. Our lab has identified numerous markers within this region and we have compiled these markers into a haplotype based test in order to identify dogs that carry JADD. We believe that in addition to the markers that distinguish affected puppies from unaffected ones, the actual mutation responsible for JADD is included in this haplotype test. The mutation responsible for JADD causes a change in the amino acid sequence in a highly conserved region of a protein. This mutation is not present in any other breeds of dogs based on testing of over 250 individual animals in 80 different breeds. However, additional research is needed to demonstrate how this mutation causes JADD in Tollers. We offer the test now to help breeders avoid producing affected puppies while we continue to understand the mechanism of the mutation. Please contact researchers if you have an affected puppy and would like to participate in the project (dlbannasch@ucdavis.edu). The mode of inheritance: This form of the disease is inherited as an autosomal recessive disease meaning that affected puppies inherited one mutant copy of this gene from each of their parents. In addition, JADD is not completely penetrant meaning that not all puppies with two copies of the mutation will go on to develop the disease. Based upon our research, approximately 75% of puppies with two copies of the mutation and haplotype will develop Addison s disease. The test: JADD Probable N/N JADD Probable N/A JADD Probable A/A This dog has two normal copies of the JADD region This dog has one mutant (abnormal) copy of the JADD region This dog has two mutant (abnormal) copies of the JADD region and has a 75% chance of developing Addison s disease by 1 year of age. In order to keep the costs of this test low it will be run in batches of 48 samples which could affect the turnaround time for results. Counseling: JADD is inherited as an autosomal recessive disease meaning that animals have only one mutant copy of the region (N/A) are normal but they are carriers of the disease and they can produce affected puppies if bred to an affected dog (A/A) or another carrier (N/A). At the time that this test was released approximately 20% of Tollers carry JADD (N/A); however, the number of carriers can change with each generation. Dogs that are carriers (N/A) are normal themselves and can be safely bred to N/N dogs in order to maintain diversity within the breed and select for other positive attributes in carrier dogs. If you have a dog identified as being A/A or having early onset Addison s disease (<1 year old) and you would like to participate in further research to understand this disease please contact Danika Bannasch DVM PhD, dlbannasch@ucdavis.edu. Page 2 of 5

JADD Key points: This is a haplotype test which includes the probable mutation as well as informative markers across the region therefore the status of a dog is reported as probable. This disease is autosomal recessive with 75% penetrance. Meaning that 75% of dogs with two copies of the mutation will get Addison s disease, the other 25% will not. Neither the decreased penetrance nor the probable designation precludes using clear by parentage for litters of puppies born of parents tested to be clear. Adult onset Addison s is a separate disease. JADD is characterized by Addison s disease occurring under 1 year of age and possible other autoimmune problems. Based on the clinical histories of 20 dogs affected with JADD, those with Addison s disease had both mineralicorticoid and glucocorticoid deficiency by 12 months of age. Most had eye problems and some had other autoimmune diseases. Comparison of age (in months) in JADD and NON-JADD cases Average Median Youngest Oldest JADD (20 dogs) 5.3 4 2 12 NON-JADD (17 dogs) 52.5 60 6 120 In making testing decisions, one should not assume that a historical case of Addison s was JADD or not based on age of onset of the disease. We are continuing to work on this disease and will be grateful for information and samples from affected dogs. Cleft Palate (CP1) in the Nova Scotia Duck Tolling Retriever (NSDTR) A cleft palate is a birth defect whereby a hole (cleft) in the roof of the mouth (palate) develops in a puppy during gestation. Puppies born with cleft palate can experience difficulty nursing which will greatly increase their risk of developing aspiration pneumonia - a serious life threatening condition. There are multiple genetic causes of cleft palate within the NSDTR breed; however, the most common form has been identified as CP1. The mutation test we have developed identifies carriers of CP1 within the NSDTR breed. It does not apply to any breed other than the NSDTR. If you have a puppy of a different breed with cleft palate and you wish to participate in the identification of the gene(s) responsible please contact the Bannasch Laboratory at the University of California at Davis (ztwolf@ucdavis.edu). Discovery: Scientists from the Bannasch Laboratory at the University of California, Davis have discovered the genetic cause of ONE FORM of cleft palate in the Nova Scotia Duck Tolling Retriever. Dogs with this form of cleft palate have a large insertion into a gene known to affect the proper development of the palate. This mutation is not present in any other breed based on testing conducted on over 300 individual animals of over 80 different dog breeds. Page 3 of 5

The mode of inheritance: Cleft palate caused by CP1 is a simple autosomal recessive disease meaning that an affected puppy has inherited one mutant copy of the gene from each parent. The test: CP1 N/N CP1 N/A CP1 A/A This dog has two normal copies of CP1 This dog has one mutant (abnormal) copy of CP1 This dog has two mutant (abnormal) copies of CP1 In order to keep the cost of this test low the test will be run in batches of 48 which could affect the turnaround time for results. Counseling: CP1 is an inherited autosomal recessive disease. Animals that have only one mutant copy of CP1 (N/A) are normal but they are carriers of the disease. When two carriers are bred to each other the resulting puppies can be affected. At the time that this test was released, approximately 15% of Tollers were carriers of CP1 (N/A); however, the number of carriers can change with each generation. To date we have received 29 samples from North American NSDTR puppies with cleft palate, 18 of which had two mutant (CP1 A/A) copies of CP1. Dogs that are carriers of CP1 (N/A) are completely normal and they can be safely bred to dogs that are non carriers of CP1 (N/N) in order to maintain diversity within the breed and to select for other positive attributes in carrier dogs. Puppies affected with cleft palate will be tested at no charge. Please contact Zena Wolf for more details (ztwolf@ucdavis.edu). CP1 Key points: There are more genetic causes of cleft palate in the breed than just CP1. We are actively working on identifying the other causes and will test puppies with cleft palates at no charge. This means that just because a puppy has a cleft does not mean it is caused by CP1 and that just because a dog is clear does not mean that it can t produce clefts from other genetic causes. In making testing decisions one should not presume that a puppy born with a cleft had the CP1 mutation. CP1 is inherited as a simple autosomal recessive. There are now five DNA tests available for the NSDTR. In addition to DNA based tests, CERF exams and hip evaluations are recommended for all breeding Tollers (CHIC). Many breeders also perform heart, patella, thyroid and elbow evaluations prior to breeding. The following table was created based on the most current data from the scientific literature and the testing company web sites in order to facilitate breeder decisions regarding DNA based tests. Page 4 of 5

Current disease related DNA tests for the NSDTR counseling information Disease Test Type Inheritance Penetrance NSDTR Penetrance Other Treatment Life Expectancy Age of onset Carrier rate prcd Mutation Recessive <100% <100% None Normal 4 yrs-never 40%*** CEA Mutation Recessive? 5-8%* None Normal Birth 5%*** DM Mutation Risk? Age related None Reduced 8-14 years? JADD Haplotype Recessive 75% N/A ~$200/month 3.75 yrs 8 wks-1 yr 20% CP1 Mutation Recessive 100% N/A Surgery** Unknown Birth 15% *Vision abnormalities **If puppy is tube fed and survives the neonatal period, the cleft can be surgically repaired ***Optigen Website Abbreviations: N/A Not Applicable N/A Not Applicable Prcd- progressive retinal atrophy CEA- Collie Eye Anomaly DM- Degenerative Myelopathy JADD-Juvenile Addison s disease CP1- Cleft Palate 1 Degenerative Myelopathy for NSDTR fits into the category of other breeds. For further information: http://www.offa.org/dnatesting/dm.html Clear by parentage would be appropriate for any of the DNA tests. Since all tests are for recessive or recessive risk mutations, if both the parents are tested clear or normal then the offspring from that cross will also all be clear or normal. The OFA currently offers this designation for one generation. Page 5 of 5